VIGIL NEUROSCIENCE INC. - COMMON STOCK
3.3100
27-September-24 15:59:57
15 minutes delayed
Stocks
+0.0400
+1.22%
Today's range
3.2771 - 3.3400
ISIN
N/A
Source
NASDAQ
-
Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
17 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Cantor Global Healthcare Conference
16 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Upcoming September Investor Conferences
29 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
13 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology Genetics
01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
30 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
24 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
18 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
18 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
27 Jun 2024 02:00:03 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present in Upcoming June Investor Conferences
30 May 2024 07:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
08 May 2024 07:40:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
07 May 2024 16:05:01 By Nasdaq GlobeNewswire
-
17 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
26 Mar 2024 07:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
20 Mar 2024 07:05:00 By Nasdaq GlobeNewswire
-
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
13 Mar 2024 07:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
12 Mar 2024 07:05:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 16:25:47 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >